CLEC1B
Basic information
Region (hg38): 12:9985642-10013424
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLEC1B gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 2 | |||||
Total | 0 | 0 | 28 | 0 | 0 |
Variants in CLEC1B
This is a list of pathogenic ClinVar variants found in the CLEC1B region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-9993168-A-T | not specified | Uncertain significance (Nov 17, 2022) | ||
12-9993258-T-A | not specified | Uncertain significance (Feb 23, 2023) | ||
12-9993267-C-G | not specified | Uncertain significance (Oct 27, 2023) | ||
12-9995176-C-G | not specified | Uncertain significance (May 27, 2022) | ||
12-9996882-A-C | not specified | Uncertain significance (Dec 02, 2022) | ||
12-9996905-T-C | not specified | Uncertain significance (Dec 26, 2023) | ||
12-9996925-T-C | not specified | Uncertain significance (Apr 27, 2022) | ||
12-9996931-C-G | not specified | Uncertain significance (Sep 20, 2023) | ||
12-9996943-T-A | not specified | Uncertain significance (Jan 03, 2024) | ||
12-9996964-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
12-9996998-C-A | not specified | Uncertain significance (Aug 28, 2023) | ||
12-9997193-C-G | not specified | Likely benign (Mar 28, 2024) | ||
12-9997202-A-T | not specified | Uncertain significance (Jun 09, 2022) | ||
12-9997207-C-A | not specified | Uncertain significance (Jan 24, 2024) | ||
12-9997207-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
12-9997215-T-A | not specified | Uncertain significance (Sep 22, 2023) | ||
12-9997220-G-C | not specified | Uncertain significance (Oct 25, 2023) | ||
12-9997235-T-C | not specified | Uncertain significance (Dec 19, 2023) | ||
12-9997238-G-C | not specified | Uncertain significance (Mar 07, 2023) | ||
12-9997249-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
12-9997256-G-T | not specified | Uncertain significance (Jul 13, 2022) | ||
12-9997259-G-C | not specified | Uncertain significance (Mar 28, 2024) | ||
12-9997262-A-G | not specified | Uncertain significance (Oct 12, 2022) | ||
12-9998309-C-A | not specified | Uncertain significance (Jan 03, 2024) | ||
12-9998317-C-A | not specified | Uncertain significance (Mar 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CLEC1B | protein_coding | protein_coding | ENST00000298527 | 6 | 27783 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.94e-8 | 0.229 | 124958 | 0 | 33 | 124991 | 0.000132 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.725 | 154 | 131 | 1.18 | 0.00000730 | 1504 |
Missense in Polyphen | 28 | 39.802 | 0.70348 | 453 | ||
Synonymous | -2.56 | 67 | 45.1 | 1.49 | 0.00000233 | 403 |
Loss of Function | 0.358 | 12 | 13.4 | 0.894 | 5.71e-7 | 157 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000526 | 0.000526 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000277 | 0.000275 |
Finnish | 0.0000466 | 0.0000463 |
European (Non-Finnish) | 0.000106 | 0.000106 |
Middle Eastern | 0.000277 | 0.000275 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: C-type lectin-like receptor that functions as a platelet receptor for the lymphatic endothelial marker, PDPN (PubMed:18215137). After ligand activation, signals via sequential activation of SRC and SYK tyrosine kinases leading to activation of PLCG2 (PubMed:18955485). {ECO:0000269|PubMed:18215137, ECO:0000269|PubMed:18955485}.; FUNCTION: (Microbial infection) Acts as an attachment factor for Human immunodeficiency virus type 1 (HIV-1) and facilitates its capture by platelets (PubMed:16940507). {ECO:0000305|PubMed:16940507}.;
- Pathway
- C-type lectin receptor signaling pathway - Homo sapiens (human);GPVI-mediated activation cascade;Platelet activation, signaling and aggregation;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.0990
Intolerance Scores
- loftool
- 0.763
- rvis_EVS
- 0.68
- rvis_percentile_EVS
- 85.04
Haploinsufficiency Scores
- pHI
- 0.0980
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.405
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.179
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Clec1b
- Phenotype
- immune system phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);
Gene ontology
- Biological process
- defense response;cell surface receptor signaling pathway;signal transduction by protein phosphorylation;platelet activation;platelet formation
- Cellular component
- plasma membrane;integral component of plasma membrane
- Molecular function
- transmembrane signaling receptor activity;protein binding;carbohydrate binding